{"id":18513,"date":"2024-07-29T11:21:04","date_gmt":"2024-07-29T17:21:04","guid":{"rendered":"https:\/\/limblecmms.com\/?p=18513"},"modified":"2025-05-30T13:00:54","modified_gmt":"2025-05-30T19:00:54","slug":"21-cfr-part-211","status":"publish","type":"post","link":"https:\/\/limblecmms.com\/blog\/21-cfr-part-211\/","title":{"rendered":"Understanding 21 CFR part 211"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p><span style=\"font-weight: 400;\">The U.S. <\/span><span style=\"font-weight: 400;\">Food and Drug Administration<\/span><span style=\"font-weight: 400;\"> (<\/span><span style=\"font-weight: 400;\">FDA<\/span><span style=\"font-weight: 400;\">) is the federal agency charged with overseeing the manufacturing, marketing, and distribution processes of various consumer goods including foods, cosmetics, pharmaceuticals, and <\/span><span style=\"font-weight: 400;\">medical devices<\/span><span style=\"font-weight: 400;\">. This means the <\/span><span style=\"font-weight: 400;\">Food and Drug Administration<\/span><span style=\"font-weight: 400;\"> is also the chief <\/span><span style=\"font-weight: 400;\">regulatory<\/span><span style=\"font-weight: 400;\"> agency presiding over the companies that produce these goods.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">As part of the United States Department of Health and Human Services (DHHS), the <\/span><span style=\"font-weight: 400;\">FDA<\/span><span style=\"font-weight: 400;\"> plays a central role in promoting public health across the nation. To perform its duties, the <\/span><span style=\"font-weight: 400;\">FDA<\/span><span style=\"font-weight: 400;\"> enforces a set of rules that are outlined in the <\/span><span style=\"font-weight: 400;\">Code of Federal Regulations<\/span><span style=\"font-weight: 400;\"> (CFR). CFR <\/span><a href=\"https:\/\/limblecmms.com\/maintenance-definitions\/21-cfr\/\"><span style=\"font-weight: 400;\">Title 21 (or <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\">)<\/span><\/a><span style=\"font-weight: 400;\"> is the section of the Code articulating the rules concerning the <\/span><span style=\"font-weight: 400;\">FDA<\/span><span style=\"font-weight: 400;\">.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">The role of <\/span><span style=\"font-weight: 400;\">FDA<\/span> <span style=\"font-weight: 400;\">21 CFR Part<\/span><span style=\"font-weight: 400;\"> 211<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\"> includes a detailed set of rules for governing <\/span><span style=\"font-weight: 400;\">medical device<\/span><span style=\"font-weight: 400;\"> and <\/span><span style=\"font-weight: 400;\">pharmaceutical manufacturing<\/span><span style=\"font-weight: 400;\"> companies. <\/span><span style=\"font-weight: 400;\">21 CFR Part<\/span><span style=\"font-weight: 400;\"> 211 is of particular importance to the pharmaceutical and <\/span><span style=\"font-weight: 400;\">medical device<\/span><span style=\"font-weight: 400;\"> manufacturing industries. This section details <\/span><span style=\"font-weight: 400;\">Current Good Manufacturing Practices<\/span><span style=\"font-weight: 400;\"> for <\/span><span style=\"font-weight: 400;\">Finished Pharmaceuticals<\/span><span style=\"font-weight: 400;\"> and includes a wide range of rules, regulations, and <\/span><span style=\"font-weight: 400;\">laboratory controls<\/span><span style=\"font-weight: 400;\"> that impact how the <\/span><a href=\"https:\/\/limblecmms.com\/blog\/preventive-maintenance-program\/\"><span style=\"font-weight: 400;\">maintenance program<\/span><\/a><span style=\"font-weight: 400;\"> for a <\/span><span style=\"font-weight: 400;\">drug manufacturing<\/span><span style=\"font-weight: 400;\"> company must operate.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">What is <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\">?\u00a0<\/span><\/h2>\n<p><a href=\"https:\/\/help.limblecmms.com\/en\/articles\/5581493-21-cfr-faqs\"><span style=\"font-weight: 400;\">Title 21 of the <\/span><span style=\"font-weight: 400;\">Code of Federal Regulations<\/span><\/a><span style=\"font-weight: 400;\"> is a collection of rules and regulations used by the <\/span><span style=\"font-weight: 400;\">FDA<\/span><span style=\"font-weight: 400;\"> to govern a variety of consumer industries including foods, cosmetics, <\/span><span style=\"font-weight: 400;\">medical devices<\/span><span style=\"font-weight: 400;\">, tobacco, pharmaceuticals, radiological devices, biological products, and more.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The <\/span><span style=\"font-weight: 400;\">FDA<\/span><span style=\"font-weight: 400;\">\u2019s mission is to ensure these consumer goods are produced safely, marketed honestly, and distributed under the proper conditions. The <\/span><span style=\"font-weight: 400;\">general provisions<\/span><span style=\"font-weight: 400;\"> of <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\"> are designed to provide the <\/span><span style=\"font-weight: 400;\">FDA<\/span><span style=\"font-weight: 400;\"> with a <\/span><span style=\"font-weight: 400;\">regulatory<\/span><span style=\"font-weight: 400;\"> framework for communicating, implementing, and enforcing these rules.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Key Components of <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\"> include:\u00a0<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Part 11 &#8211; Electronic Records; Electronic Signatures<\/b><span style=\"font-weight: 400;\">, which establishes criteria for electronic records and signatures and includes requirements for system <\/span><span style=\"font-weight: 400;\">validation<\/span><span style=\"font-weight: 400;\">, audit trails, and record retention<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Part 58 &#8211; Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies<\/b><span style=\"font-weight: 400;\">, which sets standards for the conduct, data integrity, and study reliability of nonclinical laboratory studies<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Part 211 &#8211; <\/b><b>Current Good Manufacturing Practice<\/b><b> for <\/b><b>Finished Pharmaceuticals<\/b><b> (<\/b><b>cGMP<\/b><b>)<\/b><span style=\"font-weight: 400;\">, which ensures that drugs are produced consistently and meet quality standards<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Part 312 &#8211; Investigational New Drug Application (IND)<\/b><span style=\"font-weight: 400;\">, which outlines requirements for preclinical testing, clinical study design, reporting, and applying to gain <\/span><span style=\"font-weight: 400;\">FDA<\/span><span style=\"font-weight: 400;\"> approval for human clinical trials<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Part 314 &#8211; Applications for <\/b><b>FDA<\/b><b> Approval to Market a New Drug<\/b><span style=\"font-weight: 400;\">, which specifies the criteria, content, and format for New Drug Applications (NDAs) and Abbreviated New Drug Applications (ANDAs)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Part 820 &#8211; Quality System Regulation (QSR) for <\/b><b>Medical Devices<\/b><span style=\"font-weight: 400;\">, which establishes requirements for internal <\/span><span style=\"font-weight: 400;\">quality control<\/span><span style=\"font-weight: 400;\"> systems in the design, manufacture, packaging, <\/span><span style=\"font-weight: 400;\">labeling<\/span><span style=\"font-weight: 400;\">, storage, and servicing of <\/span><span style=\"font-weight: 400;\">medical devices<\/span><span style=\"font-weight: 400;\">\u00a0\u00a0\u00a0\u00a0<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">Who does <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\"> apply to?\u00a0<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\"> regulations apply to organizations across a broad spectrum of industries such as food producers, cosmetics companies, clinical research organizations, pharmaceutical companies, and <\/span><span style=\"font-weight: 400;\">medical device<\/span><span style=\"font-weight: 400;\"> manufacturers.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Maintenance plays an important role in ensuring <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\"> compliance in all of these industries by performing a variety of tasks that improve alignment with <\/span><span style=\"font-weight: 400;\">FDA<\/span><span style=\"font-weight: 400;\"> rules and regulations. An effective maintenance program will help to ensure <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\"> compliance through:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/limblecmms.com\/maintenance-definitions\/routine-maintenance\/\"><b>Routine inspections<\/b><\/a><span style=\"font-weight: 400;\">, regular testing, and scheduled <\/span><span style=\"font-weight: 400;\">calibration<\/span><span style=\"font-weight: 400;\"> of physical assets involved in production<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/limblecmms.com\/strategies\/preventive-maintenance\/\"><b>Preventive maintenance (PM) strategies<\/b><\/a><span style=\"font-weight: 400;\"> including scheduled lubrication, cleaning, sanitation, spare parts replacement, and upkeep against normal wear and tear<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Validation<\/b><b> and qualification<\/b><span style=\"font-weight: 400;\"> of equipment and systems used in the production of regulated products<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Corrective and Preventive Actions (CAPA)<\/b><span style=\"font-weight: 400;\">, with <\/span><a href=\"https:\/\/limblecmms.com\/blog\/how-to-organize-a-maintenance-department\/\"><span style=\"font-weight: 400;\">maintenance teams<\/span><\/a><span style=\"font-weight: 400;\"> playing a primary role in identifying, addressing, and preventing the recurrence of issues that could lead to failure or non-compliance<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Documentation of maintenance activities<\/b><span style=\"font-weight: 400;\">, <\/span><span style=\"font-weight: 400;\">control records<\/span><span style=\"font-weight: 400;\">, <\/span><span style=\"font-weight: 400;\">distribution records<\/span><span style=\"font-weight: 400;\">, and more<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Comprehensive record-keeping<\/b><span style=\"font-weight: 400;\"> of all maintenance activities including details of maintenance performed, relevant dates, personnel involved, and any issues identified and resolved in the performance of maintenance duties<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">Why are <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\"> regulations important?\u00a0<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">The <\/span><span style=\"font-weight: 400;\">FDA<\/span><span style=\"font-weight: 400;\"> plays a critical role in protecting the public. <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\"> regulations govern everything from the sanitary conditions of <\/span><a href=\"https:\/\/limblecmms.com\/industry\/food-and-beverage-maintenance-software\/\"><span style=\"font-weight: 400;\">food production<\/span><\/a><span style=\"font-weight: 400;\"> and the sterility of pharmaceutical laboratories to the efficacy of hospital beds and the quality of cosmetic products.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A world without <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\"> regulations would present a frightening reality for consumers and businesses alike. Without this layer of <\/span><span style=\"font-weight: 400;\">regulatory<\/span><span style=\"font-weight: 400;\"> oversight, customers would face safety risks and struggle to access quality products. Businesses would face diminished public trust, unsafe working conditions, and dramatically heightened legal liability.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Simply stated, the <\/span><span style=\"font-weight: 400;\">FDA<\/span><span style=\"font-weight: 400;\"> is a vital <\/span><span style=\"font-weight: 400;\">regulatory<\/span><span style=\"font-weight: 400;\"> agency and <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\"> lays out the framework for its mission. Among its responsibilities, the <\/span><span style=\"font-weight: 400;\">FDA<\/span><span style=\"font-weight: 400;\">:\u00a0<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Ensures products are safe<\/b><span style=\"font-weight: 400;\"> for consumption and use, prohibits the marketing of unsafe or ineffective products, and mandates stringent product manufacturing and <\/span><span style=\"font-weight: 400;\">quality assurance<\/span><span style=\"font-weight: 400;\"> standards<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Provides guidelines <\/b><span style=\"font-weight: 400;\">for <\/span><span style=\"font-weight: 400;\">labeling operations<\/span><span style=\"font-weight: 400;\"> including <\/span><span style=\"font-weight: 400;\">labeling control<\/span><span style=\"font-weight: 400;\"> and <\/span><span style=\"font-weight: 400;\">labeling issuance<\/span><span style=\"font-weight: 400;\"> rules as well as rules surrounding <\/span><span style=\"font-weight: 400;\">expiration dating<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Monitors compliance<\/b><span style=\"font-weight: 400;\"> through inspections and audits, oversees ethical conduct in clinical trials, and ensures the protection of human subjects<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Facilitates innovation<\/b><span style=\"font-weight: 400;\"> by providing a clear <\/span><span style=\"font-weight: 400;\">regulatory<\/span><span style=\"font-weight: 400;\"> pathway for the approval of new products and by creating the stable <\/span><span style=\"font-weight: 400;\">regulatory<\/span><span style=\"font-weight: 400;\"> environment needed to foster effective R&amp;D<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Monitors post-market safety <\/b><span style=\"font-weight: 400;\">of goods and products by tracking adverse events, <\/span><span style=\"font-weight: 400;\">complaint files<\/span><span style=\"font-weight: 400;\">, and product recalls, as well as continuously assessing the safety and effectiveness of marketed products.<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">Which components of <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\"> are most relevant to maintenance professionals?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Maintenance teams will perform a wide variety of tasks that fall under the conditions outlined in <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\">.\u00a0<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Part 11 &#8211; Electronic Records; Electronic Signatures <\/b><span style=\"font-weight: 400;\">requires that electronic records and signatures used to document maintenance activities meet standards of reliability and credibility equivalent to paper records.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Part 58 &#8211; Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies <\/b><span style=\"font-weight: 400;\">sets standards for the maintenance and <\/span><span style=\"font-weight: 400;\">calibration<\/span><span style=\"font-weight: 400;\"> of equipment used in nonclinical studies.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Part 210 &#8211; <\/b><b>Current Good Manufacturing Practice<\/b><b> (<\/b><b>cGMP<\/b><b>) in Manufacturing, Processing, Packing, or Holding of Drugs <\/b><span style=\"font-weight: 400;\">provides <\/span><span style=\"font-weight: 400;\">general requirements<\/span><span style=\"font-weight: 400;\"> for a wide variety of maintenance activities aimed at ensuring the quality of <\/span><span style=\"font-weight: 400;\">drug products<\/span><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Part 211 &#8211; <\/b><b>Current Good Manufacturing Practice<\/b><b> for <\/b><b>Finished Pharmaceuticals<\/b> <span style=\"font-weight: 400;\">outlines the detailed requirements concerning the maintenance of equipment and facilities used to produce <\/span><span style=\"font-weight: 400;\">finished pharmaceuticals<\/span><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Part 820 &#8211; Quality System Regulation for <\/b><b>Medical Devices<\/b> <span style=\"font-weight: 400;\">applies to the maintenance of equipment used in the design, manufacturing, and servicing of <\/span><span style=\"font-weight: 400;\">medical devices<\/span><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Part 820.72 &#8211; <\/b><b>Calibration<\/b><b> and Maintenance of Equipment <\/b><span style=\"font-weight: 400;\">addresses the specific requirements for the <\/span><span style=\"font-weight: 400;\">calibration<\/span><span style=\"font-weight: 400;\"> and maintenance of equipment.<\/span><\/li>\n<\/ul>\n<h2><span style=\"font-weight: 400;\">Understanding <\/span><span style=\"font-weight: 400;\">21 CFR Part<\/span><span style=\"font-weight: 400;\"> 211<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">21 CFR Part<\/span><span style=\"font-weight: 400;\"> 211 provides the specifications that maintenance teams must follow when servicing the equipment and facilities used to create <\/span><span style=\"font-weight: 400;\">finished pharmaceuticals<\/span><span style=\"font-weight: 400;\">. Maintenance plays an absolutely essential role in ensuring the effectiveness of manufacturing equipment, the safety of the working environment, and the sanitary conditions of the production facilities involved in producing these often life-saving goods.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">For this reason, Part 211 is a distinctly detailed and comprehensive section of <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\">. Part 211 covers everything from facility requirements and equipment maintenance to <\/span><span style=\"font-weight: 400;\">personnel qualifications<\/span><span style=\"font-weight: 400;\"> and documentation practices. <\/span><span style=\"font-weight: 400;\">21 CFR Part<\/span><span style=\"font-weight: 400;\"> 211 has a direct impact on many day-to-day activities of businesses and their maintenance teams including:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Quality control<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Personnel training<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/limblecmms.com\/industry\/facility-maintenance-software\/\"><span style=\"font-weight: 400;\">Facility maintenance<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Equipment Management<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Documentation and Recordkeeping<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Process controls<\/span><span style=\"font-weight: 400;\"> and testing<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">21 CFR Part<\/span><span style=\"font-weight: 400;\"> 211 requirements<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">As noted above, Part 211 is a particularly detailed section of <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\">. Below, we highlight a few sections and <\/span><span style=\"font-weight: 400;\">subchapters<\/span><span style=\"font-weight: 400;\"> of <\/span><span style=\"font-weight: 400;\">21 CFR Part<\/span><span style=\"font-weight: 400;\"> 211 that offer specific guidelines for maintenance <\/span><span style=\"font-weight: 400;\">personnel responsibilities<\/span><span style=\"font-weight: 400;\">.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Subpart C<\/b><b> &#8211; Buildings and Facilities, <\/b><span style=\"font-weight: 400;\">which outlines required facility design and construction features (\u00a7211.42); HVAC system requirements (\u00a7211.46); and rules for facility cleaning and sanitation (\u00a7211.56)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Subpart D<\/b><b> &#8211; Equipment, <\/b><span style=\"font-weight: 400;\">which dictates that the <\/span><span style=\"font-weight: 400;\">equipment design<\/span><span style=\"font-weight: 400;\"> and <\/span><span style=\"font-weight: 400;\">equipment construction<\/span><span style=\"font-weight: 400;\">, as well as size and location of equipment, must facilitate ease of use, cleaning, and maintenance (\u00a7211.63); and which requires maintenance teams to establish regular maintenance schedules, comprehensive record-keeping, and <\/span><span style=\"font-weight: 400;\">written procedures<\/span><span style=\"font-weight: 400;\"> for cleaning and maintaining equipment (\u00a7211.67).\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Subpart E<\/b><b> &#8211; <\/b><b>Control of Components<\/b><b> and <\/b><b>Drug Product Containers<\/b><b> and <\/b><b>Closures<\/b><b>, <\/b><span style=\"font-weight: 400;\">requires maintenance teams to establish procedures preventing the contamination of (\u00a7211.80), and specifying the conditions for cleaning (\u00a7211.94), components, containers, and <\/span><span style=\"font-weight: 400;\">closures<\/span><span style=\"font-weight: 400;\">.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Subpart J<\/b><b> &#8211; Records and Reports, <\/b><span style=\"font-weight: 400;\">outlines <\/span><span style=\"font-weight: 400;\">general requirements<\/span><span style=\"font-weight: 400;\"> for recordkeeping (\u00a7211.180) as well as specifications for logging <\/span><span style=\"font-weight: 400;\">equipment cleaning<\/span><span style=\"font-weight: 400;\"> and use (\u00a7211.182) and recording details on <\/span><span style=\"font-weight: 400;\">batch production<\/span><span style=\"font-weight: 400;\"> and control data (\u00a7211.188).<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Other relevant components of Part 211 include rules for drug <\/span><span style=\"font-weight: 400;\">stability testing<\/span><span style=\"font-weight: 400;\"> and <\/span><span style=\"font-weight: 400;\">retesting<\/span><span style=\"font-weight: 400;\">, pharmaceutical product <\/span><span style=\"font-weight: 400;\">compounding<\/span><span style=\"font-weight: 400;\">, and other <\/span><span style=\"font-weight: 400;\">special testing requirements<\/span><span style=\"font-weight: 400;\"> related to the <\/span><span style=\"font-weight: 400;\">drug manufacturing process<\/span><span style=\"font-weight: 400;\">.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">21 CFR Part<\/span><span style=\"font-weight: 400;\"> 211 compliance<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">The <\/span><span style=\"font-weight: 400;\">FDA<\/span><span style=\"font-weight: 400;\"> has full authority to enforce the rules outlined in <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\">. The federal agency has several mechanisms at its disposal to enforce these rules. Below are some of the steps the <\/span><span style=\"font-weight: 400;\">FDA<\/span><span style=\"font-weight: 400;\"> may take when conducting inspections or enforcing the conditions of <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\">.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>On-site inspections <\/b><span style=\"font-weight: 400;\">may include facility tours, <\/span><span style=\"font-weight: 400;\">production record reviews<\/span><span style=\"font-weight: 400;\">, assessments of <\/span><span style=\"font-weight: 400;\">laboratory records<\/span><span style=\"font-weight: 400;\">, interviews with personnel, <\/span><span style=\"font-weight: 400;\">drug product inspections<\/span><span style=\"font-weight: 400;\">, and collections of samples such as raw materials or environmental swabs.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Detailed inspection findings<\/b><span style=\"font-weight: 400;\"> will be documented in an Establishment Inspection Report (EIR), which summarizes all inspection findings and any required actions.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Observed deficiencies<\/b><span style=\"font-weight: 400;\"> during inspection are reported in Form 483, which requires the impacted organization to respond with an outline of <\/span><a href=\"https:\/\/limblecmms.com\/maintenance-definitions\/corrective-maintenance\/\"><span style=\"font-weight: 400;\">corrective actions<\/span><\/a><span style=\"font-weight: 400;\"> and a projected timeline for resolution.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Serious violations<\/b><span style=\"font-weight: 400;\"> may result in the issuance of a warning letter, the seizure of impacted products, or a court-ordered injunction aimed at halting production and\/or distribution.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Severe cases<\/b><span style=\"font-weight: 400;\"> of non-compliance or fraud may result in criminal prosecution.<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">Tips for staying compliant with <\/span><span style=\"font-weight: 400;\">21 CFR Part<\/span><span style=\"font-weight: 400;\"> 211<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">You can take many steps to ensure your organization\u2019s compliance with <\/span><span style=\"font-weight: 400;\">21 CFR Part<\/span><span style=\"font-weight: 400;\"> 211. Many of these steps will align with efforts to improve your organization\u2019s maintenance program as a whole.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Below, we provide a few basic tips for staying compliant with <\/span><span style=\"font-weight: 400;\">FDA<\/span> <span style=\"font-weight: 400;\">21 CFR Part<\/span><span style=\"font-weight: 400;\"> 211:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Develop <\/b><a href=\"https:\/\/limblecmms.com\/blog\/standard-operating-procedure-sop\/\"><b>Standard Operating Procedures (SOPs)<\/b><\/a><span style=\"font-weight: 400;\"> for all aspects of manufacturing, <\/span><span style=\"font-weight: 400;\">quality control<\/span><span style=\"font-weight: 400;\">, and maintenance.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Provide ongoing employee training <\/b><span style=\"font-weight: 400;\">on <\/span><span style=\"font-weight: 400;\">cGMP<\/span><span style=\"font-weight: 400;\"> requirements and specific procedures relevant to individual roles.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Maintain detailed records<\/b><span style=\"font-weight: 400;\"> of all <\/span><span style=\"font-weight: 400;\">manufacturing processes<\/span><span style=\"font-weight: 400;\">, <\/span><span style=\"font-weight: 400;\">quality control<\/span><span style=\"font-weight: 400;\"> tests, <\/span><span style=\"font-weight: 400;\">warehousing procedures<\/span><span style=\"font-weight: 400;\">, and equipment maintenance activities.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Conduct periodic internal compliance audits<\/b><span style=\"font-weight: 400;\"> to identify deficiencies and make proactive improvements.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Establish a robust <\/b><b>quality control<\/b><b> program<\/b><span style=\"font-weight: 400;\"> to monitor product quality at every stage of production.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Implement <\/b><a href=\"https:\/\/limblecmms.com\/strategies\/preventive-maintenance\/\"><b>preventive maintenance<\/b><\/a><b> (PM) strategies<\/b><span style=\"font-weight: 400;\"> to ensure equipment is operating correctly, safely, and efficiently, as well as to prevent breakdowns and minimize unplanned downtime.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Calibrate, test, and lubricate <\/b><b>electronic equipment<\/b> <span style=\"font-weight: 400;\">regularly, and maintain detailed logs of these maintenance activities.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Follow cleaning schedules<\/b><span style=\"font-weight: 400;\">, carry out sanitation procedures, and ensure <\/span><span style=\"font-weight: 400;\">control of microbiological contamination<\/span><span style=\"font-weight: 400;\"> in all laboratory, manufacturing, packaging, and storage areas.<\/span><\/li>\n<\/ul>\n<h2><span style=\"font-weight: 400;\">CMMS and <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Limble\u2019s leading-edge <\/span><a href=\"https:\/\/limblecmms.com\/cmms\/cmms-software\/\"><span style=\"font-weight: 400;\">Computerized Maintenance Management System (CMMS)<\/span><\/a><span style=\"font-weight: 400;\"> is a powerful tool designed to help organizations streamline their maintenance activities and improve compliance with <\/span><span style=\"font-weight: 400;\">regulatory<\/span><span style=\"font-weight: 400;\"> standards, including <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\">.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Limble supports compliance with the <\/span><span style=\"font-weight: 400;\">FDA<\/span><span style=\"font-weight: 400;\">\u2019s regulations through:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Automated preventive maintenance scheduling <\/b><span style=\"font-weight: 400;\">including schedules for routine <\/span><span style=\"font-weight: 400;\">calibration<\/span><span style=\"font-weight: 400;\">, cleaning, and testing<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Comprehensive recordkeeping <\/b><span style=\"font-weight: 400;\">including maintenance logs and detailed audit trails<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Real-time monitoring <\/b><span style=\"font-weight: 400;\">and detailed reporting on key performance indicators (KPIs) related to maintenance activities and outcomes<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Training and certification management<\/b><span style=\"font-weight: 400;\"> including automated alerts indicating that employee certifications are due for renewal<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Automatic Work Order generation, <\/b><span style=\"font-weight: 400;\">management, and task delegation; and<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Compliance checklists <\/b><span style=\"font-weight: 400;\">to ensure all maintenance tasks are performed in adherence to internal safety protocols as well as both <\/span><span style=\"font-weight: 400;\">FDA<\/span><span style=\"font-weight: 400;\"> guidelines and <\/span><a href=\"https:\/\/limblecmms.com\/blog\/achieve-osha-compliance-and-ace-audits-with-cmms-software\/\"><span style=\"font-weight: 400;\">OSHA standards<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">To learn more about how Limble supports <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\"> compliance and powers more strategic maintenance programs,<\/span><a href=\"https:\/\/limblecmms.com\/resources\/21-cfr-compliance-toolkit\/?utm_campaign=21%20CFR%20Toolkit&amp;utm_source=website&amp;utm_medium=mutiny&amp;utm_content=compliance_page\"> <span style=\"font-weight: 400;\">download our <\/span><span style=\"font-weight: 400;\">21 CFR<\/span><span style=\"font-weight: 400;\"> Compliance Toolkit today<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p>[vc_row content_placement=&#8221;middle&#8221; css_animation=&#8221;fadeInDown&#8221; kd_background_image_position=&#8221;vc_row-bg-position-top&#8221; css=&#8221;.vc_custom_1699310630716{margin-top: 30px !important;margin-bottom: 50px !important;padding-top: 50px !important;padding-bottom: 50px !important;background-color: #dde4e8 !important;border-radius: 20px !important;}&#8221;][vc_column width=&#8221;2\/3&#8243; css=&#8221;.vc_custom_1699310302582{padding-left: 25px !important;}&#8221;]<header class=\"kd-section-title col-lg-12 text-left  subtitle-below-title    vc_custom_1707422252950\" ><h3 class=\"separator_off\" >Free 21 CFR Compliance Toolkit<\/h3><p class=\"subtitle\" >Our toolkit is chockful of useful information to give direction to your maintenance team as it navigates complex 21 CFR rules. <\/p><\/header><a  href=\"https:\/\/limblecmms.com\/resources\/21-cfr-compliance-toolkit\/\"  target=\"_self\"  title=\"Download Now\"  class=\"tt_button tt_primary_button btn_primary_color  button-center button-action-link icon_right\" ><span class=\"prim_text\">Get the Guide<\/span><span class=\"fas fa-angle-right iconita\" ><\/span><\/a>[\/vc_column][vc_column width=&#8221;1\/3&#8243;][vc_single_image source=&#8221;external_link&#8221; external_img_size=&#8221;256&#215;350&#8243; alignment=&#8221;center&#8221; css=&#8221;.vc_custom_1716905999305{padding-bottom: 10px !important;}&#8221; custom_src=&#8221;https:\/\/limblecmms.com\/wp-content\/uploads\/21CFR-Toolkit-Book-Image-2.png&#8221;][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>The U.S. Food and Drug Administration (FDA) is the federal [&hellip;]<\/p>\n","protected":false},"author":77,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[736],"tags":[],"class_list":["post-18513","post","type-post","status-publish","format-standard","hentry","category-compliance-safety"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.7.1 (Yoast SEO v25.7) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Understanding 21 CFR Part 211 | Limble CMMS<\/title>\n<meta name=\"description\" content=\"This article discusses the FDA\u2019s role in regulating drug and medical device manufacturers and takes a closer look at 21 CFR Part 211.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/limblecmms.com\/learn\/compliance-safety\/21-cfr-part-211\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Understanding 21 CFR Part 211 | Limble CMMS\" \/>\n<meta property=\"og:description\" content=\"This article discusses the FDA\u2019s role in regulating drug and medical device manufacturers and takes a closer look at 21 CFR Part 211.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/limblecmms.com\/learn\/compliance-safety\/21-cfr-part-211\/\" \/>\n<meta property=\"og:site_name\" content=\"Limble CMMS\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/limblecmms\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-29T17:21:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-30T19:00:54+00:00\" \/>\n<meta name=\"author\" content=\"bBrinton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@LimbleCMMS\" \/>\n<meta name=\"twitter:site\" content=\"@LimbleCMMS\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"bBrinton\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/limblecmms.com\/blog\/21-cfr-part-211\/\",\"url\":\"https:\/\/limblecmms.com\/learn\/compliance-safety\/21-cfr-part-211\/\",\"name\":\"Understanding 21 CFR Part 211 | Limble CMMS\",\"isPartOf\":{\"@id\":\"https:\/\/limblecmms.com\/#website\"},\"datePublished\":\"2024-07-29T17:21:04+00:00\",\"dateModified\":\"2025-05-30T19:00:54+00:00\",\"author\":{\"@id\":\"https:\/\/limblecmms.com\/#\/schema\/person\/3e46a42975c0af638fd3f8d68520ea39\"},\"description\":\"This article discusses the FDA\u2019s role in regulating drug and medical device manufacturers and takes a closer look at 21 CFR Part 211.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/limblecmms.com\/learn\/compliance-safety\/21-cfr-part-211\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/limblecmms.com\/#website\",\"url\":\"https:\/\/limblecmms.com\/\",\"name\":\"Limble CMMS\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/limblecmms.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/limblecmms.com\/#\/schema\/person\/3e46a42975c0af638fd3f8d68520ea39\",\"name\":\"bBrinton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/limblecmms.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e5e5528a76b45a9a618c5c97759972e48268f2eaa3b58aa18c80235beeccbf46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e5e5528a76b45a9a618c5c97759972e48268f2eaa3b58aa18c80235beeccbf46?s=96&d=mm&r=g\",\"caption\":\"bBrinton\"},\"url\":\"https:\/\/limblecmms.com\/blog\/author\/bbrinton\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Understanding 21 CFR Part 211 | Limble CMMS","description":"This article discusses the FDA\u2019s role in regulating drug and medical device manufacturers and takes a closer look at 21 CFR Part 211.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/limblecmms.com\/learn\/compliance-safety\/21-cfr-part-211\/","og_locale":"en_US","og_type":"article","og_title":"Understanding 21 CFR Part 211 | Limble CMMS","og_description":"This article discusses the FDA\u2019s role in regulating drug and medical device manufacturers and takes a closer look at 21 CFR Part 211.","og_url":"https:\/\/limblecmms.com\/learn\/compliance-safety\/21-cfr-part-211\/","og_site_name":"Limble CMMS","article_publisher":"https:\/\/www.facebook.com\/limblecmms\/","article_published_time":"2024-07-29T17:21:04+00:00","article_modified_time":"2025-05-30T19:00:54+00:00","author":"bBrinton","twitter_card":"summary_large_image","twitter_creator":"@LimbleCMMS","twitter_site":"@LimbleCMMS","twitter_misc":{"Written by":"bBrinton","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/limblecmms.com\/blog\/21-cfr-part-211\/","url":"https:\/\/limblecmms.com\/learn\/compliance-safety\/21-cfr-part-211\/","name":"Understanding 21 CFR Part 211 | Limble CMMS","isPartOf":{"@id":"https:\/\/limblecmms.com\/#website"},"datePublished":"2024-07-29T17:21:04+00:00","dateModified":"2025-05-30T19:00:54+00:00","author":{"@id":"https:\/\/limblecmms.com\/#\/schema\/person\/3e46a42975c0af638fd3f8d68520ea39"},"description":"This article discusses the FDA\u2019s role in regulating drug and medical device manufacturers and takes a closer look at 21 CFR Part 211.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/limblecmms.com\/learn\/compliance-safety\/21-cfr-part-211\/"]}]},{"@type":"WebSite","@id":"https:\/\/limblecmms.com\/#website","url":"https:\/\/limblecmms.com\/","name":"Limble CMMS","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/limblecmms.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/limblecmms.com\/#\/schema\/person\/3e46a42975c0af638fd3f8d68520ea39","name":"bBrinton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/limblecmms.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e5e5528a76b45a9a618c5c97759972e48268f2eaa3b58aa18c80235beeccbf46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e5e5528a76b45a9a618c5c97759972e48268f2eaa3b58aa18c80235beeccbf46?s=96&d=mm&r=g","caption":"bBrinton"},"url":"https:\/\/limblecmms.com\/blog\/author\/bbrinton\/"}]}},"_links":{"self":[{"href":"https:\/\/limblecmms.com\/wp-json\/wp\/v2\/posts\/18513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/limblecmms.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/limblecmms.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/limblecmms.com\/wp-json\/wp\/v2\/users\/77"}],"replies":[{"embeddable":true,"href":"https:\/\/limblecmms.com\/wp-json\/wp\/v2\/comments?post=18513"}],"version-history":[{"count":0,"href":"https:\/\/limblecmms.com\/wp-json\/wp\/v2\/posts\/18513\/revisions"}],"wp:attachment":[{"href":"https:\/\/limblecmms.com\/wp-json\/wp\/v2\/media?parent=18513"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/limblecmms.com\/wp-json\/wp\/v2\/categories?post=18513"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/limblecmms.com\/wp-json\/wp\/v2\/tags?post=18513"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}